Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.54 -0.58 (-6.36%)
At close: Sep 18, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Prepaid Assets (2022 - 2026)

Aspire Biopharma Holdings' (ASBP) quarterly Prepaid Assets came in at $1.0 million in Q2 2026, up 28.95% year-over-year from $783189.0 in Q2 2025, and up 13.46% quarter-over-quarter from $890149.0 in Q1 2026.

Analysis

Aspire Biopharma Holdings (ASBP) Prepaid Assets (2022 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has reported Prepaid Assets for 5 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 28.95% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 28.95% increase from a year earlier, with the FY2025 full-year figure at $55102.0, down 61.83% from the prior year.
  • Prepaid Assets was $1.0 million for Q2 2026 at Aspire Biopharma Holdings, up from $890149.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $1.0 million in Q2 2026 and troughed at $43052.0 in Q2 2024.
  • A 5-year average of $462600.4 and a median of $591303.0 in 2023 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets sank 89.77% in 2024 and surged 1719.17% in 2025, its largest moves.
  • Over 5 years, Prepaid Assets stood at $600493.0 in 2022, then plunged by 86.47% to $81223.0 in 2023, then surged by 77.73% to $144356.0 in 2024, then tumbled by 61.83% to $55102.0 in 2025, then jumped by 1732.89% to $1.0 million in 2026.
  • The last three Prepaid Assets figures came in at $1.0 million (Q2 2026), $890149.0 (Q1 2026), and $55102.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Aspire Biopharma Holdings 64.13 Mn 51.96 Mn -30,086.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Mn
Mar 31, 2026 890,149.00
Dec 31, 2025 55,102.00
Sep 30, 2025 419,421.00
Jun 30, 2025 783,189.00
Mar 31, 2025 618,971.00
Dec 31, 2024 144,356.00
Jun 30, 2024 43,052.00
Mar 31, 2024 65,577.00
Dec 31, 2023 81,223.00
Sep 30, 2023 253,082.00
Jun 30, 2023 420,943.00
Mar 31, 2023 591,303.00
Dec 31, 2022 600,493.00
Sep 30, 2022 613,357.00
Jun 30, 2022 629,129.00
Mar 31, 2022 644,901.00